accepted
on 10 Jun 2023
Last Applicant/ Owned by
150 SIGNET DRIVE
TORONTO
CA
M9L1T9
Serial Number
86958335 filed on 30th Mar 2016
Registration Number
5099243 registered on 13th Dec 2016
Correspondent Address
Jessica G. Kraver
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
APOTEX PHARMACEUTICAL Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatmentRead More
Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes
30th Nov 2011
30th Nov 2011
No 86958335
No Service/Collective Mark
No 338625-00025
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Jul 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 19th Jul 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 19th Jul 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 19th Jul 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 19th Jul 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 19th Jul 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 19th Jul 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 10th Jun 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 10th Jun 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 10th Jun 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
